Prelude Capital Management’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-20,812
| Closed | -$334K | – | 2014 |
|
|
2020
Q2 | $334K | Buy |
20,812
+2,179
| +12% | +$35K | 0.02% | 383 |
|
|
2020
Q1 | $289K | Buy |
18,633
+3,630
| +24% | +$56.3K | 0.02% | 219 |
|
|
2019
Q4 | $369K | Buy |
15,003
+14,301
| +2,037% | +$352K | 0.01% | 383 |
|
|
2019
Q3 | $7K | Sell |
702
-71,998
| -99% | -$718K | ﹤0.01% | 1049 |
|
|
2019
Q2 | $912K | Buy |
72,700
+71,755
| +7,593% | +$900K | 0.04% | 191 |
|
|
2019
Q1 | $12K | Sell |
945
-253
| -21% | -$3.21K | ﹤0.01% | 1037 |
|
|
2018
Q4 | $7K | Buy |
1,198
+642
| +115% | +$3.75K | ﹤0.01% | 1140 |
|
|
2018
Q3 | $6K | Buy |
+556
| New | +$6K | ﹤0.01% | 1260 |
|
|
2017
Q2 | – | Sell |
-23,243
| Closed | -$399K | – | 1844 |
|
|
2017
Q1 | $399K | Sell |
23,243
-4,979
| -18% | -$85.5K | 0.04% | 331 |
|
|
2016
Q4 | $341K | Buy |
+28,222
| New | +$341K | 0.04% | 369 |
|
|
2015
Q2 | – | Sell |
-2,400
| Closed | -$45K | – | 2047 |
|
|
2015
Q1 | $45K | Sell |
2,400
-5,400
| -69% | -$101K | 0.01% | 1294 |
|
|
2014
Q4 | $147K | Buy |
7,800
+2,300
| +42% | +$43.3K | 0.02% | 783 |
|
|
2014
Q3 | $149K | Buy |
5,500
+4,200
| +323% | +$114K | 0.02% | 772 |
|
|
2014
Q2 | $40K | Sell |
1,300
-1,600
| -55% | -$49.2K | 0.01% | 1326 |
|
|
2014
Q1 | $66K | Buy |
+2,900
| New | +$66K | 0.01% | 1043 |
|